For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

Genentech has long been known for innovation, but that reputation has been questioned in the wake of multiple rounds of layoffs and the company’s closure of its cancer immunology group.

Dr. Beck’s extensive experience in CMC and product development will be instrumental as Abata enters clinical development this ...

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...

Pharmaceutical stocks largely shook off the brunt of negotiated drug prices. But that doesn't mean they'll be spared election noise.

The biotech believes that azelaprag can amplify ... The company has also announced the appointment of former Genentech and Alladapt Immunotherapeutics executive Dana McClintock as chief medical ...